Julie-An Talano

Trials

Studies that name Julie-An Talano as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:06 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT04049383 · CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL

  Medical College of Wisconsin · terminated · Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia Recurrent · principal investigator
• Ph2
  NCT02600208 · Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device

  Julie-An M. Talano · active not recruiting · Hematologic Malignancies · principal investigator
• Ph1
  NCT01535885 · Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV

  Medical College of Wisconsin · completed · Epstein-Barr Virus Infections, Adenovirus, Cytomegalovirus Infections · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.